Figure 7From: KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cellsIn vivo activity of ARRY-520 and Paclitaxel. EOC tumors were established s.c. in female nude mice and treatments were given as described in the Materials and Methods section. Tumor size was determined by caliper measurements. (a) A2780 xenograft model and (b) tumors established from a primary culture of EOC cells.Back to article page